Recombinant Human MICA (C-6His)(Cat. No.:C489) novoprotein

$70.00
In stock
SKU
C489
10μg: $70 50μg: $220 500μg: $1225 1mg: $1750

Description

Recombinant Human MHC Class I Polypeptide-Related Sequence A is produced by our Mammalian expression system and the target gene encoding Glu24-Gln308 is expressed with a 6His tag at the C-terminus.

Product Details

ItemDetails
Known AsMHC Class I Polypeptide-Related Sequence A; MIC-A; MICA; PERB11.1
Mol Mass33.87 KDa
APMol Mass60 KDa, reducing conditions
Formulation DescriptionLyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Endotoxin< 1 EU/µg as determined by LAL test.
ReconstitutionAlways centrifuge tubes before opening.Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100μg/ml.
Dissolve the lyophilized protein in distilled water.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
StorageLyophilized protein should be stored at ≤ -20°C, stable for one year after receipt.
Reconstituted protein solution can be stored at 2-8°C for 2-7 days.
Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months.
ShippingThe product is shipped at ambient temperature.
Upon receipt, store it immediately at the temperature listed below.

Background

MHC Class I Polypeptide-Related Sequence A (MICA) is a transmembrane glycoprotein that functions as a ligand for human NKG2D. Unlike classical MHC class I molecules, MICA does not form a heterodimer with beta-2-microglobulin. MICA shares 85% amino acid identity with a closely related protein, MICB. MICA acts as a stress-induced self-antigen that is recognized by NK cells, NKT cells, and most of the subtypes of T cells. As a Ligand for the KLRK1/NKG2D receptor, MICA binds to KLRK1 leads to cell lysis. MICA functions as an antigen for gamma delta T cells and is frequently expressed in epithelial tumors. MICA antigens are able to elicit the synthesis of alloantibodies in transplant recipients. Studies have shown that anti-MICA antibodies are associated with acute renal allograft rejection and failure. MICA recognition is involved in tumor surveillance, viral infections, and autoimmune diseases.

title: An epitope-directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA/B α1/2 shedding
authors: Rui Wang, Jingni Wu, Yifeng Lin, Yufei Xiao, Bin Yang, Sheng Yao, Tianhui Pan, Zhixuan Fu, Shuyu Li, Caihua Wang, Yongliang Zhu
date: 2025/02/24
journal: Cell Reports Medicine

MDSD

Datasheet

Reviews

Write Your Own Review
You're reviewing:Recombinant Human MICA (C-6His)(Cat. No.:C489) novoprotein
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.